Table A7:
Acute Kidney Injury Stage 2 to 3
| Author, Year N (TAVI/SAVR) |
30 Days | 1 Year |
|---|---|---|
| Mack et al, 201918 950 (496/454) PARTNER 3 |
KM estimatea, n (%) TAVI: 2 (0.4) SAVR: 8 (1.8) HR (95% CI) 1.44 (0.56–0.73) RD (95% CI)b −1.4% (−3.2% to 0.7%) |
Not reported |
| Popma et al, 201917 1,403 (725/678) Evolut LRT |
TAVI: 0.9%b SAVR: 2.8%b RD (95% BCrI) −1.8 (−3.4 to −0.5) |
TAVI: 0.9%b SAVR: 2.8%b RD (95% BCrI) −1.8 (−3.4 to −0.5) |
Abbreviations: BCrI, Bayesian credible interval; CI; confidence interval; KM; Kaplan-Meier; RD, risk difference; HR hazard ratio; RD, risk difference; SAVR, surgical aortic valve replacement; TAVI, transcatheter aortic valve implantation.
a
Percentages provided are Kaplan-Meier estimates at the specific time point and do not necessarily equal the number of patients who experienced the event divided by the total number of patients in the treatment group at the given time point.
b
Calculated by the authors of this report using the exact method.24